Advertisement
Screener

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Payments of Stock Issuance Costs

CERO THERAPEUTICS HOLDINGS, INC. Payments of Stock Issuance Costs

CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Payments of Stock Issuance Costs of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-14

  • CERO THERAPEUTICS HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • CERO THERAPEUTICS HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $0.00.
  • CERO THERAPEUTICS HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $362.22K.
  • CERO THERAPEUTICS HOLDINGS, INC. payments of stock issuance costs for fiscal 2022 was $0.00.
Period endPayments of Stock Issuance Costs 3 monthPayments of Stock Issuance Costs 6 monthPayments of Stock Issuance Costs 7 monthPayments of Stock Issuance Costs 12 month
2026-06-30$0.00
10-Q · filed 2026-08-14
$0.00
derived: sum of 2 quarters · filed 2026-08-14
2026-03-31$0.00
10-Q · filed 2026-08-14
2025-06-30$362.22K
10-Q · filed 2026-08-14
2022-12-31$0.00
10-K · filed 2023-03-24
2021-12-31$944.32K
10-K · filed 2023-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
IN8BIO, INC. (INAB)United States$0.012B-0.76
CURIS INC (CRIS)United States$0.002B-0.05